Skip to main content

The effect of acupuncture on exercise capacity in patients with COPD is mediated by improvements of dyspnea and leg fatigue: a causal mediation analysis using data from a randomized controlled trial

Abstract

Background

Acupuncture is known to improve exercise capacity in patients with chronic obstructive pulmonary disease (COPD), but its mechanism remains unknown. Whether acupuncture improves exercise capacity in patients with COPD through alleviation of leg fatigue and dyspnea is examined by applying causal mediation analysis to previous trial data.

Methods

Sixty-two patients with COPD completed treatments with either real or placebo acupuncture once a week for 12 weeks. Walk distance measured using the 6-minute walk test and intensities of leg fatigue and dyspnea in the modified Borg scale were evaluated at baseline and after treatment. The intervention effect of acupuncture against the placebo acupuncture on two mediators, changes in leg fatigue and dyspnea, and whether they mediated improvements in walk distance, were analyzed.

Results

Linear regression analysis showed that the unstandardized regression coefficients [95% confidence interval (CI)] for the intervention effect by acupuncture were -4.9 (-5.8–-4.0) in leg fatigue and -3.6 (-4.3–-2.9) in dyspnea. Mediation analysis showed that when changes in leg fatigue were considered as a mediator, direct effect, indirect effect and proportion mediated were 47.1 m (95% CI, 4.6–85.1), 34.3 m (-2.1–82.1), and 42.1%, respectively, and when changes in dyspnea were considered as a mediator, they were 9.8 m (-32.9–49.9), 72.5 m (31.3–121.0), and 88.1%, respectively, and the effects of joint mediator were -5.8 m (-55.4–43.9), 88.9 m (32.7–148.5), and 107.0%, respectively.

Conclusion

The improvement in exercise capacity by acupuncture is explained by changes in both leg fatigue and dyspnea.

Peer Review reports

Introduction

Patients with chronic obstructive pulmonary disease (COPD) are affected by multiple factors, such as ventilatory limitation, gas exchange limitation, cardiac limitation, lower limb muscle dysfunction and respiratory muscle dysfunction, and their exercise is restrained mainly due to worsened leg fatigue and dyspnea during exertion [1,2,3,4]. This exercise intolerance is a predictor of mortality and exacerbation-related hospitalization for patients with COPD [5, 6], and is also associated with quality of life and physical activity [7, 8]; therefore, improvement regarding exercise intolerance is an important therapeutic goal [9].

Pharmacological therapies such as bronchodilators and pulmonary rehabilitation can reduce symptoms in patients with COPD, as well as improve their exercise capacity. However, according to the longitudinal analysis of the data from the Swedish National Register of COPD, 74% of the patients who inhaled triple therapy of long-acting muscarinic antagonists, long-acting beta-2-agonists and inhalation corticosteroids along with physiotherapy had persistent dyspnea that interfered with activities with a modified medical research council score of 2 or higher, which indicates that the current standard treatment alone is not sufficient [10].

On the other hand, reports of acupuncture use for COPD have been increasing in recent years. Our previous randomized controlled trials showed that acupuncture improved exercise capacity in patients with COPD, and other clinical trials have subsequently reported the same effect [11,12,13]. However, it is not well understood how acupuncture improves exercise capacity in patients with COPD. Since the majority of patients with COPD stop exercising due to dyspnea and leg fatigue [2,3,4], the effects of acupuncture may have been achieved through alleviation of these symptoms. However, no studies to date have investigated this. Therefore, by applying causal mediation analysis to the existing clinical trial data [11], we investigated how much of the improvement in exercise capacity for patients with COPD induced by acupuncture can be explained by its alleviating effects in leg fatigue and dyspnea.

Methods

Study design and patients

This study was a secondary analysis of data from previous randomized, single-blind, placebo-controlled, and parallel group trial to see the effects of acupuncture on patients with COPD. Details of the trial design have previously been published [11], so we will describe them briefly. The trial was conducted in the Kansai region of Japan between July 2006 and March 2009. Sixty-eight patients who were diagnosed as having stage II, III, or IV COPD, in accordance with the definition and criteria of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, were assigned to the real acupuncture group (n = 34) or the placebo group (n = 34). The trial was conducted in accordance with the Declaration of Helsinki and its amendments, as well as the Guidelines for Good Clinical Practice for Epidemiological Studies and Clinical Research issued by the Japanese Ministry of Health, Labour and Welfare, and the research protocol is registered in the UMIN Clinical Trials Registry (UMIN000001277). In the previous trial, written informed consent was obtained from all participants. This study used only the data collected from this previous trial. Therefore, we disclosed information about this study on our website and provided the participants with the chance to opt-out. The Research Ethics Committee of Meiji University of Integrative Medicine approved this study (Approval number 2021-016).

This study included 62 participants who completed the protocol for each treatment group and had a complete dataset of mediators and outcomes at baseline and follow-up.

Intervention

Patients in the real acupuncture group received acupuncture treatment once a week for 12 weeks in addition to daily medication. The standardized acupuncture points used in the previous study were: Zhongfu (LU 1) and Taiyuan (LU 9) in the lung meridian; Futu (LI 18) in the large intestine meridian; Guanyuan (CV 4) and Zhongwan (CV 12) in the conception vessel; Zusanli in the stomach meridian (ST 36); Taixi (KI 3) in the kidney meridian; Wangu in the gallbladder meridian (GB12); and Feishu (BL 13), Pishu (BL 20), and Shenshu (BL 23) in the bladder meridian [11]. These acupuncture points were selected based on the past research on acupuncture for pulmonary dysfunction [14, 15] and the literature describing traditional acupuncture point prescriptions for bronchial asthma and chronic bronchitis. And some other acupuncture points (such as Futu [LI18] and Wangu [GB12]) which are on the accessory muscles of respiration were added. Treatment frequency was determined based on our previous matched-pair study showing the efficacy of once-weekly acupuncture [15]. For the placebo group, placebo acupuncture needles, Park sham devices, which have a blunt needle tip and can be retracted while still appearing to pierce the skin, were used [16]. The real and placebo needles appear similar and are the same size (0.35 mm × 70 mm, stainless steel, Dong Bang Acupuncture Inc., Bundang, Seongnam, Korea).

For the real acupuncture group, needles were inserted to a depth ranging from 5 to 25 mm and manually rotated clockwise and counter-clockwise for 3–4 min at each point during 50-min treatment periods. No electrical stimulation was performed. Perception of de qi (tingling, numbness, heaviness, and other feelings that occur after an acupuncture needle is inserted) during insertion and/or manipulation was confirmed at each point.

The placebo group underwent treatment at the same acupuncture points and frequency as the real acupuncture group. Perception of sensation during treatment sessions in the placebo group included pricking or poking.

Patients in both groups were informed in advance that both real and placebo acupuncture needles could cause some sensations. The acupuncturist asked patients if they felt any sensations, which could be considered “de qi”, during the treatment, but they were not informed that such sensations were peculiar to real acupuncture. Evaluation of blinding at the end of the trial revealed that the blinding was successful and patients were unable to distinguish between real and placebo acupuncture [11, 17].

Outcome and mediators

A 6-minute walk test was performed at baseline and postintervention, and changes in walk distance in meters from baseline were evaluated as outcomes [18]. Immediately after the walk test, the intensities of leg fatigue and dyspnea were measured by the modified 10-point Borg category ratio scale and the changes from baseline were evaluated as mediators [19].

We hypothesized the relationship between intervention (A), two mediators (M1, M2), outcome (Y), and covariates (C) as shown in Fig. 1. This hypothesis was based on the following reported findings: exercise capacity in patients with COPD is mainly limited by leg fatigue and dyspnea [2,3,4]; experimentally induced leg fatigue in healthy subjects exacerbates dyspnea on exertion [20, 21]; inhibition of sensory muscle afferents in legs by spinal anesthesia improves dyspnea during exercise and exercise capacity inpatients with COPD [22]; acupuncture is likely to improve muscle fatigue [23]; acupuncture clinical trials for patients with COPD observed improvement in exercise capacity as well as improvement in dyspnea on exertion [11,12,13]. Therefore, we considered the possible mechanism of acupuncture to improve exercise capacity in patients with COPD by hypothesizing the following pathways; one affecting leg fatigue but not affecting dyspnea (path A-M1-Y in Fig. 1), one first affecting leg fatigue and subsequently affecting dyspnea (path A-M1-M2-Y), one directly affecting dyspnea (path A-M2-Y), and one which does not belong to any of the above (path A-Y).

Fig. 1
figure 1

Assumed causal graph

The relationships between intervention (A), mediators (M1 and M2), outcome (Y), and covariates (C) that were assumed in this study are shown

Covariates

The measured values of the 6-minute walk distance, leg fatigue, and dyspnea at baseline were considered covariates in mediation analysis. For sensitivity analysis, we added age and baseline values of body mass index (kg/m2) and inspiratory capacity (L) to the covariates. These were selected since they are variables that could affect both outcome and mediators [6, 24,25,26,27].

Statistical analysis

For the baseline characteristic values, mean ± standard deviation was calculated for the continuous variables, and frequency was calculated for the categorical variables. To assess the intervention effect of acupuncture against the placebo acupuncture on each of the two mediators, we fitted a linear regression model conditional on the baseline values and intervention groups respectively, and then estimated the unstandardized regression coefficients with 95% Confidence Intervals (CI).

Causal mediation analysis was performed to decompose the total effect (TE) of acupuncture against the placebo acupuncture on the 6-minute walk distance into the natural direct effect (NDE) and the natural indirect effect (NIE) [28]. NDE is, to put it simply, the effect of intervention on the outcome that works through non-mediator mechanisms, and NIE is the effect through a mediator. We performed mediation analyses when leg fatigue, dyspnea, and their joints were considered mediators, respectively. By doing these analyses, we were able to assess the extent to which the effects of acupuncture were explained by each mediator. In addition, by comparing the mediation effects (i.e., NIE) when leg fatigue was considered as a mediator and when leg fatigue and dyspnea were considered jointly, we were able to assess the magnitude of the effect of the pathway that directly affected dyspnea not through leg fatigue (path A-M2-Y in Fig. 1). Furthermore, by comparing the sum of the individual NIE of leg fatigue and dyspnea with the joint NIE, we were able to assess the possibility that mediators affect one another. We performed the mediation analysis using a simulation-based approach using the “Direct Counterfactual Imputation Estimation” implemented in the R package “CMAverse” [29, 30]. This approach requires regression models for the mediator and for the outcome. First, we estimated NDE, NIE, TE, and the proportion mediated (PM = NIE divided by TE) when the changes in leg fatigue (M1) were considered as the mediator. We fitted a linear regression model for the M1 conditional on the intervention group (A) and covariates (C), which included baseline values of 6-minute walk distance, leg fatigue, and dyspnea, and a linear regression model for the outcome (Y) conditional on A, M1, the product term of A and M1, and C. Next, we estimated NDE, NIE, TE, and PM when the changes in dyspnea (M2) were considered as the mediator. We estimated a linear regression model for the M2 conditional on A and C, and a linear regression model for the Y conditional on A, M2, the product term of A and M2, and C. Thirdly, we estimated the NDE, NIE, TE, and PM when M1 and M2 were considered joint mediators [31]. We used the same linear regression models previously estimated for M1 and M2, and estimated a linear regression model for the Y conditional on A, M1, M2, the product term of A and M1, the product term of A and M2, and C.

We performed two sensitivity analyses. First, in order to evaluate the robustness to the addition of covariates, the simulation-based approach was performed again after adding age and the baseline values of body mass index and inspiratory capacity to covariates. Second, a weighting approach was performed to evaluate the robustness to the different approaches for effect estimation [31]. In order to implement the weighting approach, outcome and exposure models are required. So, for the outcome model, we fitted a regression model similar to the simulation-based approach, and for the exposure model we fitted a logistic regression model for intervention A conditional on C. The weighting approach was carried out using “The Weighting-based Approach” implemented in the R package “CMAverse” [30]. The 95% CIs for each effect in all mediation analyses were obtained using 1,000 bootstraps. All analyses were performed using R software (version 4.1.1).

Results

Participants

Of the 111 people who met the inclusion and exclusion criteria, 68 participated in the trial, and they were randomly assigned to a real or placebo acupuncture group with 34 each. Finally, 62 participants (30 in the real acupuncture group, 32 in the placebo group) who completed the protocol and had a complete dataset of outcomes and mediators at baseline and follow-up were included. The baseline characteristics of the subjects in each group are shown in Table 1. Information about the medications used on the subjects has been provided in the previous study [11]. All medications remained unchanged throughout the study period.

Table 1 Baseline characteristics of study participants

Effects on leg fatigue and dyspnea

Acupuncture yielded a clear therapeutic effect compared to the placebo for both leg fatigue and dyspnea (Table 2). As a result of the linear regression analysis, the unstandardized regression coefficient (95% CI) of the real acupuncture group compared with that of the placebo group was -4.8 (-5.8–-3.9) for leg fatigue and -3.6 (-4.3–-2.9) for dyspnea.

Changes in variables other than those analyzed in this study have been reported in previous studies [11]. Variables measured before and after the test included oxyhemoglobin saturation as measured by pulse oximetry, St George Respiratory Questionnaire Score, Medical Research Council dyspnea scale, body mass index, prealbumin level, arterial blood gas, rib cage range of motion, pulmonary function and the respiratory muscle strength.

Table 2 Linear regression analysis for changes in leg fatigue and dyspnea at the end of walking test

Mediation analysis

The results of the mediation analysis are shown in Table 3. In the simulation-based approach, when the changes in leg fatigue from baseline to postintervention were considered as the mediator, the TE of the real acupuncture against the placebo acupuncture regarding 6-min walk distance was 81.4 m (95% CI: 55.2–109.4), where the NDE (not mediated by changes in leg fatigue) was 47.1 m (4.6–85.2), the NIE (mediated) was 34.3 m (-2.1–82.1), and the PM was 42.1%. When the changes in dyspnea were considered as the mediator, the TE was 82.3 m (57.4–110.3), and the NDE, NIE, and PM were 9.8 m (-32.9–49.9), 72.5 m (31.3–121.0), and 88.1%, respectively. When the changes in leg fatigue and dyspnea were considered as the joint mediator, the TE, NDE, NIE, and PM were 82.1 m (56.7–112.6), -5.8 m (-55.4–43.9), 88.9 m (32.7–148.5), and 107.0%, respectively. The results of the two sensitivity analyses were similar to those of the main analysis.

Table 3 Causal mediation analysis

Discussion

To our knowledge, this is the first study to examine how much of the acupuncture-induced improvement in exercise capacity in patients with COPD is mediated by alleviation of leg fatigue and dyspnea. We found that acupuncture had significant therapeutic effects regarding leg fatigue and dyspnea compared to the placebo, and that about 40% of the total effect of acupuncture on exercise capacity was explained by leg fatigue alleviation, about 90% was explained by dyspnea alleviation, and almost 100% was explained by the two together. Studies investigating the main symptoms limiting exercise of patients with COPD in the case of walking load have descriptively reported that patients stop exercising due to dyspnea (69–77% of patients), leg fatigue (16–30%), or a combination of the two symptoms (1–12%) [4, 32, 33]. Although we cannot directly compare these reports since they did not investigate the mediating effects of leg fatigue and dyspnea, their findings do not contradict our findings.

The mediation effect increased significantly when changes in dyspnea were added as mediators. This indicates that the pathway that affects dyspnea without leg fatigue (path A-M2-Y in Fig. 1) plays a major role in the mechanism by which acupuncture improves exercise capacity. Improvement of respiratory muscle function and increased endogenous opioids may be involved in this pathway. Respiratory muscle dysfunction exacerbates dyspnea during exercise in patients with COPD by increasing perceived respiratory effort [34]. We observed in the previous clinical trial that the maximum inspiratory and expiratory mouth pressure and range of motion in the rib cage increased after acupuncture intervention [11], and that these changes possibly reflected the improvement of respiratory muscle function by acupuncture. These improvements may have resulted from acupuncture applied to acupuncture points located on the accessory respiratory muscles, which increased muscle blood flow [35] and reduced excessive muscle tension [36]. It has been reported that dyspnea in patients with COPD is modulated by endogenous opioids and improved by opioid treatment [37,38,39]. Acupuncture-induced increases in endogenous opioids may contribute to the reduction of dyspnea [40].

The point estimate for the natural indirect effect on exercise capacity due to changes in leg fatigue ranged from 29.9 m for the weighting approach to 34.3 m for the simulation-based approach. This value is comparable to the minimal important difference of 25–33 m for 6-minute walk distance in adults with chronic respiratory disease [18]. Various structural and functional abnormalities occur in the lower limb muscles of patients with COPD [41], and muscle deconditioning caused by them leads to the metabolite accumulation and acidosis associated with anaerobic metabolism, which occur at the early stage of exercise [42]. Therefore, some patients stop exercising due to leg fatigue rather than dyspnea [4, 32, 33]. Muscle fatigue in patients with COPD occurs in the dorsi and plantar flexors when a walking load such as the one in this study is applied [43]. Acupuncture stimulation to acupuncture points (ST 36, KI 3 in our study) on these easily fatigued muscles could improve oxygen utilization by increasing local muscle blood flow and oxygenation and lead to a reduction of leg fatigue and improved exercise capacity [35, 44,45,46]. However, the lower bound of the confidence interval of the indirect effect due to the change in leg fatigue was slightly below zero, so its mediation effect was not definite. Further studies are needed to elucidate how much of the total improvement of exercise capacity due to acupuncture is attained by the reduction of leg fatigue. In addition, the sum of the indirect effects when the two mediators were examined individually did not match with the indirect effect when they were considered jointly. This indicates the possibility that mediators affect one another [31]. As mentioned above, patients with COPD perceive leg fatigue through the activation of muscle afferents caused by the metabolite accumulation due to muscle deconditioning at the early stage of exercise [42]. These afferent signals increase the ventilatory response and dyspnea [20, 21]. In addition, it has been reported that blocking afferent signals from the lower limb muscles by spinal anesthesia can improve dyspnea and exercise capacity in patients with COPD [22]. Considering these previous reports that investigated the effects of leg fatigue on dyspnea and exercise capacity, as we hypothesized, there could be a pathway in the acupuncture mechanism that exercise capacity is improved because the changes in leg fatigue affect dyspnea (path A-M1-M2-Y in Fig. 1).

The strength of this study is that our analysis was based on placebo-controlled trial data. There was no psychological effect on the observed acupuncture mediation effects, and it should be interpreted as the mechanism of acupuncture. There are some limitations to the current study. First, there are four assumptions that need to be met for the identification of the natural direct and indirect effects; that is, there is no unmeasured confounding in (i) the exposure-outcome relationship, (ii) the mediator-outcome relationship, (iii) or the exposure-mediator relationship. And the fourth assumption is that there are no effects of exposure that confound the mediator-outcome relationship [24]. In this study, exposure refers to acupuncture or placebo intervention, mediators refer to changes in leg fatigue and/or dyspnea, and outcome refers to changes in 6-minute walk distance. We confirmed robustness on the addition of some covariates by sensitivity analysis, but the number of covariates that could be considered was limited by the sample size. Therefore, the possibility of unmeasured confounding cannot be ruled out. In addition, it cannot be denied that the existence of time-varying confounders affected by treatment may violate the fourth assumption. Second, our analysis was based on mediators and outcome measurements evaluated at two time points, but the real relationship can be more complicated because these variables can change over time while influencing each other. Third, the small sample size or data variability might have led to wide confidence intervals for all effects. Recently, a method that can estimate the analogue of natural direct and indirect effects in the presence of a time-varying confounder has been proposed, and has been extended to the setting of multiple mediators [47, 48]. By applying this method to large sample size data measured multiple times, a more detailed and reliable mediation effect of acupuncture could be evaluated. Finally, the exercise capacity we investigated for mediation effects was limited to walking loads only. It has been reported that the symptoms that limit exercise in patients with COPD differ between walking and cycling [4, 33]. Different exercise load settings may change the extent of leg fatigue and dyspnea’s contribution to the effect of acupuncture on exercise capacity. Therefore, one should be cautious when extrapolating the results to the exercise capacity measured with the different exercise types.

Conclusion

This study showed that acupuncture improved exercise capacity (6-minute walk distance) in patients with COPD by alleviating leg fatigue and dyspnea (Borg scale). When performing acupuncture to improve exercise capacity, practitioners will likely find greater therapeutic benefits by focusing on reducing dyspnea and leg fatigue.

Data availability

The dataset supporting the conclusions of this article is available from the corresponding author, TK, upon request.

Abbreviations

COPD:

Chronic obstructive pulmonary disease

GOLD:

Global Initiative for Chronic Obstructive Lung Disease

CI:

Confidence interval

TE:

Total effect

NDE:

Natural direct effect

NIE:

Natural indirect effect

PM:

Proportion mediated

References

  1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. https://doi.org/10.1164/rccm.201309-1634ST.

    Article  PubMed  Google Scholar 

  2. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir. 1992;146(4):935–40. https://doi.org/10.1164/ajrccm/146.4.935.

    Article  CAS  PubMed  Google Scholar 

  3. O’Donnell DE, Travers J, Webb KA, He Z, Lam YM, Hamilton A, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J. 2009;34(4):866–74. https://doi.org/10.1183/09031936.00168708.

    Article  PubMed  Google Scholar 

  4. Deschenes D, Pepin V, Saey D, LeBlanc P, Maltais F. Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2008;28(3):208–14. https://doi.org/10.1097/01.HCR.0000320074.73846.3b.

    Article  PubMed  Google Scholar 

  5. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23(1):28–33. https://doi.org/10.1183/09031936.03.0003460.

    Article  CAS  PubMed  Google Scholar 

  6. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012;13(3):291–7. https://doi.org/10.1016/j.jamda.2011.06.009.

    Article  PubMed  Google Scholar 

  7. Brown CD, Benditt JO, Sciurba FC, Lee SM, Criner GJ, Mosenifar Z, et al. Exercise testing in severe emphysema: association with quality of life and lung function. COPD. 2008;5(2):117–24. https://doi.org/10.1080/15412550801941265.

    Article  PubMed  Google Scholar 

  8. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009;180(6):506–12. https://doi.org/10.1164/rccm.200812-1873OC.

    Article  PubMed  Google Scholar 

  9. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2022 report). https://goldcopd.org/wp-content/uploads/2021/11/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf. Accessed 20 Oct 2022.

  10. Sundh J, Ekstrom M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2805–12. https://doi.org/10.2147/COPD.S119992.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Suzuki M, Muro S, Ando Y, Omori T, Shiota T, Endo K, et al. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med. 2012;172(11):878–86. https://doi.org/10.1001/archinternmed.2012.1233.

    Article  PubMed  Google Scholar 

  12. Feng J, Wang X, Li X, Zhao D, Xu J. Acupuncture for chronic obstructive pulmonary disease (COPD): a multicenter, randomized, sham-controlled trial. Medicine (Baltimore). 2016;95(40):e4879. https://doi.org/10.1097/MD.0000000000004879.

    Article  CAS  Google Scholar 

  13. Li Y, Xiong C, Zeng Y, Wei H, Zhuang G, Zhao L, et al. Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial. J Tradit Chin Med. 2019;39(6):885–91.

    PubMed  Google Scholar 

  14. Jobst KA. A critical analysis of acupuncture in pulmonary disease: efficacy and safety of the acupuncture needle. J Altern Complement Med. 1995;1(1):57–85. https://doi.org/10.1089/acm.1995.1.57.

    Article  CAS  PubMed  Google Scholar 

  15. Suzuki M, Namura K, Ohno Y, Tanaka H, Egawa M, Yokoyama Y. The effect of acupuncture in the treatment of chronic obstructive pulmonary disease. J Altern Complement Med. 2008;14(9):1097–105. https://doi.org/10.1089/acm.2007.0786.

    Article  PubMed  Google Scholar 

  16. Park J, White A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002;20(4):168–74. https://doi.org/10.1136/aim.20.4.168.

    Article  PubMed  Google Scholar 

  17. Suzuki M, Ishizaki N. Acupuncture for Dyspnea on Exertion in Chronic Obstructive Pulmonary Disease: no blindness–reply. Arch Intern Med. 2012;172(22):1772–3. https://doi.org/10.1001/jamainternmed.2013.1285.

    Article  PubMed  Google Scholar 

  18. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46. https://doi.org/10.1183/09031936.00150314.

    Article  PubMed  Google Scholar 

  19. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.

    Article  CAS  PubMed  Google Scholar 

  20. Grippo A, Carrai R, Chiti L, Bruni GI, Scano G, Duranti R. Effect of limb muscle fatigue on perception of respiratory effort in healthy subjects. J Appl Physiol (1985). 2010;109(2):367–76. https://doi.org/10.1152/japplphysiol.00608.2009.

    Article  PubMed  Google Scholar 

  21. Sharma P, Morris NR, Adams L. Effect of induced leg muscle fatigue on exertional dyspnea in healthy subjects. J Appl Physiol (1985). 2015;118(1):48–54. https://doi.org/10.1152/japplphysiol.00393.2014.

  22. Gagnon P, Bussieres JS, Ribeiro F, Gagnon SL, Saey D, Gagne N, et al. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(7):606–15. https://doi.org/10.1164/rccm.201203-0404OC.

    Article  CAS  PubMed  Google Scholar 

  23. Ma H, Liu X, Wu Y, Zhang N. The intervention effects of acupuncture on fatigue Induced by Exhaustive Physical exercises: a Metabolomics Investigation. Evid Based Complement Alternat Med. 2015;2015:508302. https://doi.org/10.1155/2015/508302.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Spruit MA, Franssen FM, Rutten EP, Wagers SS, Wouters EF. Age-graded reductions in quadriceps muscle strength and peak aerobic capacity in COPD. Rev Bras Fisioter. 2012;16(2):148–56. https://doi.org/10.1590/s1413-35552012005000011.

    Article  PubMed  Google Scholar 

  25. Baig MMA, Hashmat N, Adnan M, Rahat T. The relationship of dyspnea and disease severity with anthropometric indicators of malnutrition among patients with chronic obstructive pulmonary disease. Pak J Med Sci. 2018;34(6):1408–11. https://doi.org/10.12669/pjms.346.15769.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Divo MJ, Cabrera C, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, et al. Comorbidity Distribution, clinical expression and survival in COPD patients with different body Mass Index. Chronic Obstr Pulm Dis. 2014;1(2):229–38. https://doi.org/10.15326/jcopdf.1.2.2014.0117.

    Article  PubMed  PubMed Central  Google Scholar 

  27. O’Donnell DE, Elbehairy AF, Webb KA, Neder JA. The link between reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2017;14(Supplement_1):S30–9. https://doi.org/10.1513/AnnalsATS.201610-834FR.

    Article  PubMed  Google Scholar 

  28. VanderWeele TJ. Explanation in causal inference: methods for mediation and interaction. New York: Oxford University Press; 2015.

  29. Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010;15(4):309–34. https://doi.org/10.1037/a0020761.

    Article  PubMed  Google Scholar 

  30. Shi B, Choirat C, Coull BA, VanderWeele TJ, Valeri L. CMAverse: A suite of functions for reproducible causal mediation analyses. Epidemiol. 2021;32(5):e20–2. https://doi.org/10.1097/EDE.0000000000001378.

    Article  Google Scholar 

  31. VanderWeele TJ, Vansteelandt S. Mediation analysis with multiple mediators. Epidemiol Methods. 2014;2(1):95–115. https://doi.org/10.1515/em-2012-0010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Marquis N, Debigare R, Bouyer L, Saey D, Laviolette L, Brouillard C, et al. Physiology of walking in patients with moderate to severe chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2009;41(8):1540–8. https://doi.org/10.1249/MSS.0b013e31819c717f.

    Article  PubMed  Google Scholar 

  33. Pepin V, Saey D, Whittom F, LeBlanc P, Maltais F. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(12):1517–22. https://doi.org/10.1164/rccm.200507-1037OC.

    Article  PubMed  Google Scholar 

  34. Charususin N, Dacha S, Gosselink R, Decramer M, Von Leupoldt A, Reijnders T, et al. Respiratory muscle function and exercise limitation in patients with chronic obstructive pulmonary disease: a review. Expert Rev Respir Med. 2018;12(1):67–79. https://doi.org/10.1080/17476348.2018.1398084.

    Article  CAS  PubMed  Google Scholar 

  35. Shinbara H, Okubo M, Sumiya E, Fukuda F, Yano T, Kitade T. Effects of manual acupuncture with sparrow pecking on muscle blood flow of normal and denervated hindlimb in rats. Acupunct Med. 2008;26(3):149–59. https://doi.org/10.1136/aim.26.3.149.

    Article  PubMed  Google Scholar 

  36. Kawakita K, Ito K, Okada K. Experimental model of trigger points using eccentric exercise. J Musculoskelet Pain. 2008;16:29–35.

    Article  Google Scholar 

  37. Ekstrom M, Nilsson F, Abernethy AA, Currow DC. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015;12(7):1079–92. https://doi.org/10.1513/AnnalsATS.201501-034OC.

    Article  PubMed  Google Scholar 

  38. Gifford AH, Mahler DA, Waterman LA, Ward J, Kraemer WJ, Kupchak BR, et al. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD. 2011;8(3):160–6. https://doi.org/10.3109/15412555.2011.560132.

    Article  PubMed  Google Scholar 

  39. Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J. 2009;33(4):771–7. https://doi.org/10.1183/09031936.00145208.

    Article  CAS  PubMed  Google Scholar 

  40. Han JS. Acupuncture and endorphins. Neurosci Lett. 2004;361(1–3):258–61. https://doi.org/10.1016/j.neulet.2003.12.019.

    Article  CAS  PubMed  Google Scholar 

  41. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62. https://doi.org/10.1164/rccm.201402-0373ST.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153(1):288–93. https://doi.org/10.1164/ajrccm.153.1.8542131.

    Article  CAS  PubMed  Google Scholar 

  43. Gagnon P, Maltais F, Bouyer L, Ribeiro F, Coats V, Brouillard C, et al. Distal leg muscle function in patients with COPD. COPD. 2013;10(2):235–42. https://doi.org/10.3109/15412555.2012.719047.

    Article  PubMed  Google Scholar 

  44. Ohkubo M, Hamaoka T, Niwayama M, Murase N, Osada T, Kime R, et al. Local increase in trapezius muscle oxygenation during and after acupuncture. Dyn Med. 2009;8(2). https://doi.org/10.1186/1476-5918-8-2.

  45. Cagnie B, Barbe T, De Ridder E, Van Oosterwijck J, Cools A, Danneels L. The influence of dry needling of the trapezius muscle on muscle blood flow and oxygenation. J Manipulative Physiol Ther. 2012;35(9):685–91. https://doi.org/10.1016/j.jmpt.2012.10.005.

    Article  PubMed  Google Scholar 

  46. Maekura T, Miki K, Miki M, et al. Clinical effects of acupuncture on the pathophysiological mechanism of Chronic Obstructive Pulmonary Disease during Exercise. Int J Chron Obstruct Pulmon Dis. 2019;14:2787–98. https://doi.org/10.2147/copd.S225694.

    Article  PubMed  PubMed Central  Google Scholar 

  47. VanderWeele TJ, Tchetgen Tchetgen EJ. Mediation analysis with time varying exposures and mediators. J R Stat Soc Series B Stat Methodol. 2017;79(3):917–38. https://doi.org/10.1111/rssb.12194.

    Article  PubMed  Google Scholar 

  48. Yamamuro S, Shinozaki T, Iimuro S, Matsuyama Y. Mediational g-formula for time-varying treatment and repeated-measured multiple mediators: application to atorvastatin’s effect on cardiovascular disease via cholesterol lowering and anti-inflammatory actions in elderly type 2 diabetics. Stat Methods Med Res. 2021;30(8):1782–99. https://doi.org/10.1177/09622802211025988.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank research assistant Rika Ishizuka (Office for Gender Equality Support at Fukushima Medical University) for her assistance in manuscript preparation.

Funding

This study received no support from anywhere, but the original trial, from which this study used the data, was supported by the Grants-in-Aid for scientific research from the Japan Society of Acupuncture and Moxibustion.

Author information

Authors and Affiliations

Authors

Contributions

TK, MS, and FF contributed to the conception and design of this study. TK analyzed the data. TK, MS, and TM interpreted data. The draft of the manuscript was created by TK. All authors reviewed and approved the final version of the manuscript.

Corresponding authors

Correspondence to Takumi Kayo or Fumihiko Fukuda.

Ethics declarations

Ethics approval and consent to participate

This study was a secondary analysis of data from the previous clinical trial [11], which was conducted in accordance with the Declaration of Helsinki and its amendments, as well as the Guidelines for Good Clinical Practice for Epidemiological Studies and Clinical Research issued by the Japanese Ministry of Health, Labour and Welfare, and the research protocol is registered in the UMIN Clinical Trials Registry (UMIN000001277). In the previous trial, written informed consent was obtained from all participants. This study used only the data collected from this previous trial. Therefore, we disclosed information about this study on our website and provided the participants with the chance to opt-out. The Research Ethics Committee of Meiji University of Integrative Medicine approved this study (Approval number 2021-016).

Consent for publication

Not applicable.

Competing interests

TK, MS, and TM are supported with a grant from Seirin Corporation. TK, MS, TM, and FF are Advisory Board Member, Executive Director, Advisor, and Director of the Japan Society of Acupuncture and Moxibustion, respectively.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kayo, T., Suzuki, M., Mitsuma, T. et al. The effect of acupuncture on exercise capacity in patients with COPD is mediated by improvements of dyspnea and leg fatigue: a causal mediation analysis using data from a randomized controlled trial. BMC Complement Med Ther 24, 44 (2024). https://doi.org/10.1186/s12906-024-04353-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-024-04353-0

Keywords